Severe piperacillin-tazobactam-induced hemolysis in a cystic fibrosis patient

Andrew D Kerkhoff1, Lauren Patrick2, Patricia Cornett1

  • 1Department of Medicine University of California San Francisco School of Medicine San Francisco California.

Clinical Case Reports
|December 12, 2017
PubMed

Insights

Piperacillin-tazobactam frequently causes drug-induced immune hemolytic anemia (DIIHA), particularly in cystic fibrosis (CF) patients. This case highlights a severe DIIHA instance and offers management strategies for CF individuals.

Area of Science:

  • Pharmacology
  • Hematology
  • Immunology

Background:

  • Piperacillin-tazobactam is a widely used antibiotic, especially in cystic fibrosis (CF) patients.
  • Drug-induced immune hemolytic anemia (DIIHA) is a known adverse effect of piperacillin-tazobactam.
  • CF patients may have unique considerations regarding antibiotic-induced complications.

Observation:

  • A 30-year-old female patient with CF developed life-threatening DIIHA.
  • The DIIHA was directly associated with piperacillin-tazobactam administration.
  • This case underscores the severity of DIIHA in this patient population.

Findings:

  • Piperacillin-tazobactam can precipitate severe, life-threatening DIIHA.
  • Early recognition and prompt management are critical for patient survival.
  • Specific management protocols may be beneficial for CF patients experiencing DIIHA.

Implications:

  • Healthcare providers should maintain a high index of suspicion for DIIHA in CF patients receiving piperacillin-tazobactam.
  • Development of tailored management guidelines for piperacillin-tazobactam-associated DIIHA in CF patients is warranted.
  • Further research into the mechanisms and prevention of DIIHA in this vulnerable population is needed.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
549
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
898
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
18
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
945
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
468
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.0K